Archives
New Alzheimer’s drug slows cognitive decline by 35 per cent
4 May 2023
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2023/05/GettyImages-1064220756-150x150.jpg)
A clinical trial has revealed a new Alzheimer’s drug can successfully slow down decline in memory and thinking by 35 per cent. Donanemab has been shown to significantly reduce cognitive decline in people with early-stage Alzheimer’s disease. The trial by US pharmaceutical company Eli Lilly showed it has been successful in removing sticky amyloid plaques […]